Skip to main content
Click Here For COVID-19 Studies
Home
Clinical Trials Office Register as a Researcher Log In
348 Studies Now Enrolling
 Menu
Home How It Works Resources Join RecruitMe

Search

Reset

Status

  • Currently Recruiting (1)
  • Closed (9)

Medical Condition

  • Show all (237)
  • Addiction (4)
  • Autoimmune Disorders (15)
  • Blood Disorders (26)
  • Bone & Muscle (1)
  • (-) Cancer (4)
    • Lymphoma (1)
  • Child Development (1)
  • Developmental Disorders (1)
  • Endocrine & Metabolic Disease (2)
  • Hair and Skin Disorders (2)
  • Healthy Volunteers (8)
  • Heart Disease (1)
  • Liver Disease (1)
  • Lung Disease (2)
  • Meniere's Disease (1)
  • Neurological Disorders (112)
  • Obstetrics & Gynecology (3)
  • Pediatrics (6)
  • Psychiatric Disorders (47)
    • ADD/ADHD (2)
    • Anxiety (4)
    • (-) Bipolar Disorder (6)
    • Borderline Personality Disorder (1)
    • Depression (19)
    • Eating Disorders (2)
    • Obsessive Compulsive Disorder (OCD) (5)
    • PTSD (2)
    • Schizophrenia (2)
Displaying 1 - 10 of 10

Research Study offering Treatment for Self-Injury (Bipolar Disorder)

Condition: Psychiatric Disorders / Bipolar Disorder
Investigator: Jeffrey Miller, MD
Status: Closed
The goal of this study is to examine how effective and well-tolerated a possible new treatment for individuals who injure themselves frequently will be. All research procedures can be done from home no in-person visits are required. We are studying a minimal-risk form of electrical brain stimulation called transcranial direct current stimulation, or tDCS.…
Read More

Lumateperone for the Treatment of Bipolar Disorder

Condition: Psychiatric Disorders / Bipolar Disorder
Investigator: David Hellerstein, MD
Status: Closed
This study is a double-blind and placebo-controlled study to assess its efficacy of the new drug Lumateperone for patients with Major Depressive Episodes associated with Bipolar I and Bipolar II disorder. Lumateperone is thought to exert its antidepressant effect through interaction with sereotogenic, dopaminergic, and glutamergic neurotransmitter targets.…
Read More

Brain imaging in bipolar depression to be able to predict who will respond to antidepressant treatment

Condition: Psychiatric Disorders / Bipolar Disorder
Investigator: Martin Lan, MD
Status: Closed
We are trying to understand what causes bipolar disorder and how medications treat bipolar depression. If you participate, you will have two different brain scans (MRI and PET scan). You will also have antidepressant treatment for free. We will then be able to see whether information on the brain scans connects with how people do on the medications. The…
Read More

Brain imaging in bipolar depression to understand the role of inflammation in its treatment.

Condition: Psychiatric Disorders / Bipolar Disorder
Investigator: Martin Lan, MD
Status: Closed
This is a research study to understand what causes bipolar disorder and how medications treat bipolar depression. Particularly, we are looking at the importance of inflammation in the process. If you participate, you will receive an experimental medication for your depression named ethyl eicosapentaenoic acid (ethyl EPA), an omega 3 fatty acid. You will…
Read More

Nivolumab in Treating Patients With Autoimmune Disorders and Advanced, Metastatic, or Unresectable Cancer

Condition: Cancer
Investigator: Brian Henick, MD
Status: Closed
This phase Ib trial studies the side effects of nivolumab and to see how well it works in treating patients with autoimmune disorders and cancer that has spread to other places in the body or cannot removed by surgery. Immunotherapy with monoclonal antibodies, such as nivolumab, may help the body…
Read More

Brain imaging in bipolar depression to understand the antidepressant mechanism of lurasidone (Latuda).

Condition: Psychiatric Disorders / Bipolar Disorder
Investigator: Martin Lan, MD
Status: Closed
We are trying to understand what causes bipolar disorder and how medications treat bipolar depression. Particularly, we are looking at the importance of dopamine signaling in the process. If you participate, you will have two different brain scans (MRI and PET scan). You will also have treatment for your depression with an FDA approved medication,…
Read More

MRI Effects of D-cycloserine & Lurasidone in Bipolar Depression

Condition: Psychiatric Disorders / Bipolar Disorder
Investigator: Joshua Kantrowitz, Md
Status: Closed
We will evaluate the D-cycloserine (DCS) and lurasidone with MRI measurement of brain responses to DCS. DCS is a drug that works on the same brain receptor as ketamine. DCS is not approved by the FDA for bipolar depression. Study participants will receive a dose of lurasidone or placebo in one MRI and a dose of DCS in another, followed by an optional follow…
Read More

Treatment Effects on Development of Chemotherapy-Induced Peripheral Neuropathy in Patients With Cancer (lung, breast, ovarian)

Condition: Cancer
Investigator: Meghna Trivedi, MD
Status: Closed
The purpose of this study is to try to learn how certain risk factors, such as age, gender, pre-existing conditions, the type of treatment you get for your cancer, and the amount of cancer drugs in your body affect whether you develop the nerve disorder and how bad your symptoms will be. There will be about 1,000 people taking part in this study.
Read More

Study of EBV-Cytotoxic T Lymphocytes (EBV-CTLs) in Patients with Epstein-Barr Virus-Associated Viremia or Malignancies

Condition: Cancer / Lymphoma
Investigator: Ran Reshef, MD
Status: Closed
Epstein-Barr Virus (EBV) is the virus that causes mononucleosis, also known as mono. Almost all adults have had EBV. For most people, EBV never causes a health problem. However, when their immune system is not working properly (people who have had a transplant and those who have immune disorders), EBV can cause certain…
Read More

Tissue Repository For The Collection of Hematologic Samples

Condition: Cancer
Investigator: Suzanne Lentzsch, MD
Status: Currently Recruiting
Subjects are being asked to volunteer to allow excess specimen (blood, bone marrow samples, samples of pleural and pericardial effusions, ascites, tissue, and bone samples) removed from patients with and who are undergoing procedures for hematological and non-hematological disorders for storage and future use. These samples…
Read More
This website uses cookies as well as similar tools and technologies to understand visitors’ experiences. By continuing to use this website, you consent to Columbia University’s usage of cookies and similar technologies, in accordance with the Columbia University Website Cookie Notice.
I AGREE
COMPLIANCE
Compliance Hotline Compliance Program
RESOURCES
Contact RecruitMe Terms of Use Privacy Policy ©2025 Columbia University
SCHOOLS
Vagelos College of Physicians and Surgeons Mailman School of Public Health School of Nursing College of Dental Medicine Graduate School of Arts and Science